Health
AstraZeneca-Oxford vaccine prevents 70% of covid cases, study shows – Sydney Morning Herald
AstraZeneca said its vaccine could be around 90 per cent effective under one of the dosing regimens tested.
Australia has signed up for 33 million doses from AstraZeneca, with global biotech company CSL already gearing up to make the vaccine in its Melbourne lab.
But Australia has three other supply deals for vaccines: 10 million doses from Pfizer and its partner BioNTech, 40 million from Novavax, and 51 million from the University of Queensland’s project.
The cost of signing up to the four potential COVID-19 vaccines is more than $3.3 billion, if they are proved to be safe and effective.
British Health…
-
General13 hours agoMontana’s house was gutted by an accidental fire. Then her landlord accused her of starting it
-
Noosa News14 hours agoUniversity of Queensland researchers survey population of endangered White’s Seahorse
-
General14 hours agoNSW to introduce independent regulator following review into early childhood sector
-
Business13 hours agoThe smartest ASX dividend stocks to buy with $5,000 right now